Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The
global chronic disease management market is anticipated to grow with a CAGR of
~13% over the forecast period, i.e., 2022 - 2031. The market is segmented by
type into solutions, and services. Out of these, solutions segment is projected
to grow at a highest pace over the forecast period owing to the heightened
awareness of the adoption of cloud-based healthcare solutions, as well as the
rising prevalence of on-demand healthcare solutions.
Get a Sample PDF of Report: https://www.researchnester.com/sample-request-4242
The
global chronic disease management market is projected to significantly grow
owing to the globally increasing chronic obstructive pulmonary disease,
followed by the upsurge in aging population, as a lot of intensive care is
required for the old people, and increasing utilization of big data in
healthcare sector are some of the major factors anticipated to drive the growth
of the market in the coming years.
Geographically,
the global chronic disease management market is segmented into five major
regions comprising of North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa. The market in the North America region is estimated
to witness significant growth over the forecast period on the back of rising
occurrence of various kinds of chronic diseases i.e., cardiovascular disease,
heart disease, diabetes and cancer, growing count of geriatric population, and
expansion in technological progressions in the region
The
research is global in nature and covers detailed analysis on the market in North
America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary,
Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway,
Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil,
Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan,
South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of
Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain,
Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and
Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and
displayed in the research report.
Browse the
full report summary: https://www.researchnester.com/reports/chronic-disease-management-market/4242
Rising
Prevalence of Various Types of Chronic Diseases to Drive the Market Growth
For instance, by 2020, global chronic disease
prevalence was boosted by 59%.
Chronic
disease is defined as one that lasts for more than a year and necessarily
requires continuous medical treatment or restricts everyday activities. Chronic
diseases i.e., diabetes, cardiovascular disease, cancer, strokes, and heart
disease are the major reasons behind the huge count of disability and death
across the globe. These diseases require long duration treatment as well as a
precise monitoring of health recovery in a patient. In such scenario, chronic
disease management gives great support by providing health monitoring on a go
by the aid of several sorts of digitally accessible tools i.e., health
monitoring apps, cloud based tool to search health related query and getting an
appropriate outcome of such queries. Therefore, the increasing number of
chronic disease patients is fueling the demand of chronic disease management.
However, high
primary investments, shortage of skilled personnel, and high treatment cost of
chronic diseases are expected to operate as key restraint to the growth of global
chronic disease management market over the forecast period.
This report
also provides the existing competitive scenario of some of the key players of
the global chronic disease management market which includes company profiling
of NXGN Management, WellSky Corporation, Epic Systems Corporation, Cedar Gate
Technologies, Koninklijke Philips N.V, Altruista Health, Cognizant TriZetto
Software Group Inc, Infosys Ltd, Pegasystems Inc., Hinduja Global Solutions
Ltd., and others. The profiling enfolds key information of the companies which
encompasses business overview, products and services, key financials and recent
news and developments. On the whole, the report depicts detailed overview of
the global chronic disease management market that will help industry
consultants, equipment manufacturers, existing players searching for expansion
opportunities, new players searching possibilities and other stakeholders to
align their market centric strategies according to the ongoing and expected trends
in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-4242
About Research Nester
Research Nester is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more
Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
%20Security%20Market.jpg)
No comments:
Post a Comment